Holen Sie sich die Stockscreener-App
23.09
3.36%
0.75
Vorhandelsmarkt:
23.09
Schlusskurs vom Vortag:
$22.34
Offen:
$22.52
24-Stunden-Volumen:
1.50M
Relative Volume:
0.85
Marktkapitalisierung:
$1.97B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
36.65
EPS:
0.63
Netto-Cashflow:
$170.92M
1W Leistung:
+7.45%
1M Leistung:
+2.49%
6M Leistung:
+42.71%
1J Leistung:
-36.76%
1-Tages-Spanne:
$22.33
$23.22
1-Wochen-Bereich:
$21.36
$23.22
52-Wochen-Spanne:
$13.39
$36.77
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Vergleichen Sie PGNY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
23.09 | 1.97B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
523.12 | 483.06B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
432.68 | 97.95B | 176.81B | 5.98B | 4.55B | 25.61 |
|
CI
Cigna Group
|
331.00 | 89.74B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
67.98 | 85.71B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
264.74 | 31.95B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
BTIG Upgrades Progyny (PGNY) - Nasdaq
Progyny expands maternal health offerings with doula services By Investing.com - Investing.com South Africa
Analyst Expectations For Progyny's Future - Benzinga
Progyny expands maternal health offerings with doula services - Investing.com India
Progyny expands materna health support with doula services - TipRanks
BTIG lifts Progyny stock rating to Buy, sets $28 target By Investing.com - Investing.com Canada
Progyny Expands Maternal Health Support with Addition of Doula Services - GlobeNewswire
Game-Changing Maternal Health Move: Progyny Adds Doula Services to Reduce Birth Complications - Stock Titan
BTIG Upgrades Progyny to Buy From Neutral, Price Target is $28 - MarketScreener
BTIG lifts Progyny stock rating to Buy, sets $28 target - Investing.com India
BTIG upgrades Progyny to Buy on improving demand - TipRanks
The past three years for Progyny (NASDAQ:PGNY) investors has not been profitable - Yahoo Finance
Commit To Buy Progyny At $17.50, Earn 12.7% Annualized Using Options - Nasdaq
James Hardie Industries, MINISO Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Progyny Clears Key Benchmark, Hitting 80-Plus RS Rating - MSN
The three-year loss for Progyny (NASDAQ:PGNY) shareholders likely driven by its shrinking earnings - simplywall.st
Progyny at KeyBanc Forum: Strategic Growth and Challenges By Investing.com - Investing.com UK
How the (PGNY) price action is used to our Advantage - Stock Traders Daily
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering - GlobeNewswire
Progyny launches Parent and Child Well-being Offering - TipRanks
Progyny Tackles 40% of Workforce Needs with Game-Changing Parent Support Solution - StockTitan
Mutual of America Capital Management LLC Has $194,000 Stock Position in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny at Leerink’s Global Healthcare Conference: Strategic Expansion Focus By Investing.com - Investing.com Canada
Progyny, Inc. to Participate in Upcoming Investor Conferences - GlobeNewswire
Exclusive Access: Progyny Leadership Reveals Growth Strategy at Triple Healthcare Conference Series - StockTitan
Amalgamated Bank Sells 1,468 Shares of Progyny, Inc. (NASDAQ:PGNY) - Defense World
Truist Financial Corp Cuts Holdings in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Decoding Progyny Inc (PGNY): A Strategic SWOT Insight - GuruFocus
Progyny, Inc. SEC 10-K Report - TradingView
Health Insurance Providers Q4 Earnings: Progyny (NASDAQ:PGNY) Simply the Best - The Globe and Mail
Progyny, Inc. (PGNY) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - ACCESS Newswire
Progyny, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Simply Wall St
Principal Financial Group Inc. Sells 419,185 Shares of Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
Rhumbline Advisers Lowers Stock Position in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny, Inc. Reports Strong 2024 Earnings with Optimistic Outlook - TipRanks
Progyny (NASDAQ:PGNY) Issues Earnings Results, Misses Estimates By $0.28 EPS - MarketBeat
Progyny (NASDAQ:PGNY) Issues Q1 2025 Earnings Guidance - MarketBeat
Expert Outlook: Progyny Through The Eyes Of 4 Analysts - Benzinga
Progyny price target raised to $23 from $17 at Canaccord - TipRanks
Progyny Tops EPS Forecast, Eyes Growth - MSN
KeyBanc maintains Progyny stock Sector Weight amid strong outlook - Investing.com India
KeyBanc maintains Progyny stock Sector Weight amid strong outlook By Investing.com - Investing.com South Africa
Progyny Tops EPS Forecast, Eyes Growth - The Motley Fool
Cantor Fitzgerald raises Progyny stock target to $26 By Investing.com - Investing.com Canada
Progyny projects slower revenue growth after losing Amazon - Crain's New York Business
Earnings call transcript: Progyny Q4 2024 beats expectations, stock surges - Investing.com India
Cantor Fitzgerald raises Progyny stock target to $26 - Investing.com
Canaccord raises Progyny stock price target to $23, maintains hold By Investing.com - Investing.com Australia
Progyny, Inc. (NASDAQ:PGNY) Q4 2024 Earnings Call Transcript - Insider Monkey
Canaccord raises Progyny stock price target to $23, maintains hold - Investing.com India
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.07%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):